Matches in Ghent University Academic Bibliography for { <https://biblio.ugent.be/publication/01GJ0JXHZ39P13A6PX1FBBRX25> ?p ?o. }
Showing items 1 to 31 of
31
with 100 items per page.
- 01GJ0JXHZ39P13A6PX1FBBRX25 classification A1.
- 01GJ0JXHZ39P13A6PX1FBBRX25 date "2023".
- 01GJ0JXHZ39P13A6PX1FBBRX25 language "eng".
- 01GJ0JXHZ39P13A6PX1FBBRX25 type journalArticle.
- 01GJ0JXHZ39P13A6PX1FBBRX25 hasPart 01GMQ8RG9X23C4K2TJ9F6E746R.pdf.
- 01GJ0JXHZ39P13A6PX1FBBRX25 subject "Medicine and Health Sciences".
- 01GJ0JXHZ39P13A6PX1FBBRX25 doi "10.1093/jac/dkac378".
- 01GJ0JXHZ39P13A6PX1FBBRX25 issn "0305-7453".
- 01GJ0JXHZ39P13A6PX1FBBRX25 issn "1460-2091".
- 01GJ0JXHZ39P13A6PX1FBBRX25 issue "1".
- 01GJ0JXHZ39P13A6PX1FBBRX25 volume "78".
- 01GJ0JXHZ39P13A6PX1FBBRX25 abstract "Background Chronic pulmonary aspergillosis (CPA) can complicate underlying pulmonary diseases, and clinical management of CPA is challenging. Guidelines support clinicians but due to the complexity of the disease they can be difficult to adhere to. Objectives To map current guideline recommendations for the clinical management of CPA into a scoring tool to facilitate and quantify guideline adherence in clinical practice. Methods Recommendations for diagnosis, treatment and follow-up of CPA presented in the current ESCMID/ERS/ECMM and CPAnet guidance documents were assembled and weighed on the basis of their strength of recommendation and level of evidence. Results Twenty-seven recommendations were identified, resulting in a total maximum EQUAL CPA Score of 51. For diagnostics (Score(Max )= 27), a strong emphasis on expert consultation, culture, direct microscopy, histopathology, serology and imaging was reflected in respective points, whereas molecular techniques and susceptibility testing count into the diagnostics score to a lesser extent. Ten treatment recommendations (Score(Max )= 14), including antifungal therapy, therapeutic drug monitoring and treatment duration, were identified. Surgery, where indicated, adds three points. For refractory disease or intolerance of first-line antifungal treatment, optimal second-line treatment added another two points. During follow-up (Score(Max )= 10), response assessment via imaging gave three points, while culture and serology added two points each to the Score(Max). Conclusion The EQUAL CPA Score intents to be used as a comprehensive tool for measuring guideline adherence. If adherence to current guidelines is associated with clinical outcome, this will be assessed in future studies.".
- 01GJ0JXHZ39P13A6PX1FBBRX25 author F85E6FEA-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:2f148fde-e3d3-4043-850c-896c68edf67c.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:321f7f5a-3854-43e1-9c5c-be846ff3f13b.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:431e7fcd-b756-421b-93c2-a3c67292ffa4.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:65d78d67-eb40-48b1-97ab-2562128338ec.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:abc598e4-00f5-45a8-8451-d99ff181943f.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:b564965e-991c-4b46-af9d-79cd12c913b0.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:bf14c224-7132-47ef-94a9-7b8b8c6ad47c.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:d7257f54-7b88-4ce7-8677-66e59c07ac8b.
- 01GJ0JXHZ39P13A6PX1FBBRX25 author urn:uuid:f02c53a4-ddb2-411a-ae60-e104164f12c0.
- 01GJ0JXHZ39P13A6PX1FBBRX25 dateCreated "2022-11-16T16:03:57Z".
- 01GJ0JXHZ39P13A6PX1FBBRX25 dateModified "2024-12-12T10:18:42Z".
- 01GJ0JXHZ39P13A6PX1FBBRX25 name "EQUAL CPA Score 2022 : a tool to measure guideline adherence for chronic pulmonary aspergillosis".
- 01GJ0JXHZ39P13A6PX1FBBRX25 pagination urn:uuid:ed8740d8-6fdc-41de-a4f4-48c8f2171d31.
- 01GJ0JXHZ39P13A6PX1FBBRX25 publisher urn:uuid:d2f5e3e0-9366-49a9-a0e6-14687f24a644.
- 01GJ0JXHZ39P13A6PX1FBBRX25 sameAs LU-01GJ0JXHZ39P13A6PX1FBBRX25.
- 01GJ0JXHZ39P13A6PX1FBBRX25 sourceOrganization urn:uuid:369e758e-558c-4a98-bc0d-3f6a8c6e28fc.
- 01GJ0JXHZ39P13A6PX1FBBRX25 sourceOrganization urn:uuid:7dbab094-ea50-4ffc-9c1e-004ee2f37022.
- 01GJ0JXHZ39P13A6PX1FBBRX25 type A1.